Loading 30M Genomics
Skip to content
FDA approved markersCPIC dosing guidelinesSaliva swab, non invasiveResults within 24 hours after sample receiptIndian population markersClinically Actionable reportsSupported by BIRAC · CCMB · IKPFDA approved markersCPIC dosing guidelinesSaliva swab, non invasiveResults within 24 hours after sample receiptIndian population markersClinically Actionable reportsSupported by BIRAC · CCMB · IKP
30M Genomics — Personalize your medicine
Careers
All products
  • Pharmacogenomics
  • Microbiomics
  • Virtual Digital Twin
  • Aiyra
  • Learning hub
  • Gallery
  • Press
  • About
  • Science
  • Contact
  • Collaborate
  • Investors
  • Clinicians

2500+Tests done in last 13 months

Request a reportEnquiry
Loading page
30M Genomics — Personalize your medicine

Pharmacogenomics and clinician tools.

Company

  • Science
  • About
  • Careers
  • Gallery
  • Press
  • Contact
  • Collaborate
  • Investors
  • Clinicians

Tests

  • Pharmacogenomics

In the pipeline

  • Preventive genomics
  • Lifestyle genomics
  • Microbiome
  • Virtual Human Twin

Products

  • Aiyra

Learning

  • All topics
  • Pharmacogenomics
  • Genetic testing
  • Genetic counselling
  • DNA testing

Legal

  • Privacy
  • Aiyra privacy
  • Terms
  • Refund
  • Shipping
  • Informed consent

Registered office

Near Church, PavulavarigudemDwarakatirumala, West GodavariAndhra Pradesh, India 534426

Operating office

5-9-262, P47, Rajiv Gandhi NagarKukatpally, HyderabadTelangana, India 500037

© 2026 30M Genomics Private Limited. All rights reserved.
EnquiryPGx
Go back to the official landing page
A person linked to a neon digital twin through a DNA health network

Under Trials

Under Trials

Virtual Digital Twin

A computational twin that layers epigenetics with pharmacokinetics (PK) and pharmacodynamics (PD) to model how a person may respond — and how to enhance treatment effect safely.

EnquirePipeline note

Overview

Concept

A virtual human twin is a working model of a person. The published 30M plan would combine epigenetics with how the body handles a drug (pharmacokinetics) and how the drug acts (pharmacodynamics). That is more than the pharmacogenomics report we issue today. It is a research and product path, not a live test.

Neon infographic of epigenetics, pharmacogenomics, pharmacokinetics, and pharmacodynamics around a virtual human twin

Layers

The layers we have described

Four research layers in the published twin plan — not a launched clinical product.

Epigenetics

How environment and regulation shape gene expression beyond the static DNA sequence.

Pharmacokinetics (PK)

How the body absorbs, distributes, metabolises, and clears a drug.

Enquire

Pharmacodynamics (PD)

How the drug acts on targets and pathways once it reaches them.

Pharmacokinetics (PK)

How the body absorbs, distributes, metabolises, and clears a drug.

Enquire

2 / 4

What is available now

The assay, the model, and clinical sign-off for this layer are not claimed as launched. The test you can book today is saliva pharmacogenomics. Partners and investigators can enquire about early access. A longer read is on the human digital twin learning page.